BE900564A - Composition pharmaceutique pour le traitement d'arteriopathies peripheriques. - Google Patents
Composition pharmaceutique pour le traitement d'arteriopathies peripheriques.Info
- Publication number
- BE900564A BE900564A BE0/213641A BE213641A BE900564A BE 900564 A BE900564 A BE 900564A BE 0/213641 A BE0/213641 A BE 0/213641A BE 213641 A BE213641 A BE 213641A BE 900564 A BE900564 A BE 900564A
- Authority
- BE
- Belgium
- Prior art keywords
- treatment
- pharmaceutical composition
- peripheral arteriopathies
- peripheral
- arteriopathies
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002093 peripheral effect Effects 0.000 title 1
- 208000005764 Peripheral Arterial Disease Diseases 0.000 abstract 1
- JNWFIPVDEINBAI-UHFFFAOYSA-N [5-hydroxy-4-[4-(1-methylindol-5-yl)-5-oxo-1H-1,2,4-triazol-3-yl]-2-propan-2-ylphenyl] dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C(C(C)C)=CC(C=2N(C(=O)NN=2)C=2C=C3C=CN(C)C3=CC=2)=C1O JNWFIPVDEINBAI-UHFFFAOYSA-N 0.000 abstract 1
- 229960004120 defibrotide Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
L'application de compositions pharmaceutiques comprenant, comme composant actif, le défibrotide permet le traitement d'artériopathies périphériques en phase avancée (phases III et IV) par une voie thérapeutique ; en forme injectable par voie intraveineuse ou intramusculaire ou par voie orale.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT22855/83A IT1170214B (it) | 1983-09-12 | 1983-09-12 | Composizione farmaceutica per la cura delle arteriopatie periferiche |
Publications (1)
Publication Number | Publication Date |
---|---|
BE900564A true BE900564A (fr) | 1985-01-02 |
Family
ID=11201215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/213641A BE900564A (fr) | 1983-09-12 | 1984-09-12 | Composition pharmaceutique pour le traitement d'arteriopathies peripheriques. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5081109A (fr) |
EP (1) | EP0137543B1 (fr) |
JP (1) | JPH0647545B2 (fr) |
AT (1) | ATE55695T1 (fr) |
BE (1) | BE900564A (fr) |
CH (1) | CH661870A5 (fr) |
DE (1) | DE3433328A1 (fr) |
IT (1) | IT1170214B (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1223322B (it) * | 1987-10-23 | 1990-09-19 | Crinos Industria Farmaco | Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso |
IT1231509B (it) * | 1989-09-07 | 1991-12-07 | Crinos Industria Farmaco | Composizione farmceutica ad uso topico per la terapia della fragilita' capillare. |
US6699985B2 (en) | 1991-08-21 | 2004-03-02 | Arsinur Burcoglu | Method of treating HIV infection and related secondary infections thereof |
DE19610345C1 (de) | 1996-03-18 | 1997-11-20 | Krupp Vdm Gmbh | Katalysator zur Oxidation von Abwasserverunreinigungen mittels Persäuren und/oder Wasserstoffperoxid |
WO1998048843A1 (fr) * | 1997-04-28 | 1998-11-05 | Arsinur Burcoglu | Traitement de l'infection par vih et de ses infections opportunistes |
ITMI20031714A1 (it) * | 2003-09-05 | 2005-03-06 | Gentium Spa | Formazioni ad azione antitumorale. |
KR20070120953A (ko) * | 2005-03-03 | 2007-12-26 | 젠티엄 에스피에이 | 항암활성을 갖는 제제 |
ATE526963T1 (de) * | 2006-05-04 | 2011-10-15 | Lek Pharmaceuticals | Pharmazeutische zusammensetzung mit olmesartan- medoxomil |
EP1872787A1 (fr) * | 2006-06-27 | 2008-01-02 | Gentium S.p.A. | Utilisation de defibrotide pour l'inhibition de l'heparanase |
EP1982722A1 (fr) * | 2007-04-16 | 2008-10-22 | Gentium S.p.A. | Utilisation de oligotide pour le traitement de maladies rénales |
EP2103689A1 (fr) * | 2008-03-19 | 2009-09-23 | Gentium S.p.A. | Oligonucléotides phosphodiesters synthétiques et leurs utilisations thérapeutiques |
DK2637672T3 (en) | 2010-11-12 | 2018-10-22 | Gentium S R L | DEFIBROTID FOR USE IN PROPHYLAXY AND / OR TREATMENT OF GRAPHIC VERSUS HOST DISEASE (GVHD) |
RU2627177C2 (ru) | 2012-06-22 | 2017-08-03 | Джентиум С.Р.Л. | Способ определения биологической активности дефибротида, основанный на применении эуглобулина |
EP3026122A1 (fr) | 2014-11-27 | 2016-06-01 | Gentium S.p.A. | Procédé à base cellulaire pour déterminer la puissance de défibrotide |
BR112020002289A2 (pt) | 2017-08-03 | 2020-07-28 | Jazz Pharmaceuticals Ireland Limited | formulações compreendendo um ácido nucleico em uma alta concentração |
MX2020010689A (es) | 2018-04-12 | 2021-01-20 | Jazz Pharmaceuticals Inc | Defibrotida para la prevencion y tratamiento del sindrome de liberacion de citocinas y la neurotoxicidad asociada con la inmunodeplecion. |
WO2020118165A1 (fr) | 2018-12-07 | 2020-06-11 | Jazz Pharmaceuticals Ireland Limited | Administration sous-cutanée de formulations à haute concentration |
EP4110287A1 (fr) | 2020-02-28 | 2023-01-04 | Jazz Pharmaceuticals Ireland Limited | Administration de formulations de faible viscosité |
WO2021212055A1 (fr) | 2020-04-17 | 2021-10-21 | Jazz Pharmaceuticals Ireland Limited | Traitement de défibrotide pour la prévention d'un rejet et d'une lésion d'organe |
WO2022234101A1 (fr) | 2021-05-06 | 2022-11-10 | Jazz Pharmaceuticals Ireland Limited | Défibrotide pour le traitement et la prévention du syndrome de détresse respiratoire aiguë |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3899481A (en) * | 1970-11-03 | 1975-08-12 | Crinos Industria Farmaco | Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs |
IT1043823B (it) * | 1970-11-03 | 1980-02-29 | Prephar | Procedimento per l estrazione di acidi nucleici da organi animali |
DE2154279A1 (de) * | 1970-11-03 | 1972-05-25 | Crinos Industria Farmaco | Medikamente für das fibrinolytische System |
US4485105A (en) * | 1978-10-12 | 1984-11-27 | American Cyanamid Company | Method of treating hyperlipidemia with 4-(monoalkylamino)benzoic acid amides |
US4416877A (en) * | 1979-02-13 | 1983-11-22 | Symphar S.A. | Anti-atherosclerotic pharmaceutical compositions containing diphosphonate compounds |
GB2043072B (en) * | 1979-02-13 | 1983-11-23 | Symphar Sa | Diphosphonate compounds |
JPS5675474A (en) * | 1979-11-22 | 1981-06-22 | Chugai Pharmaceut Co Ltd | Nicotinamide derivative and medicine containing the same |
US4351950A (en) * | 1980-01-02 | 1982-09-28 | Warner-Lambert Company | Anti-arteriosclerotic agents |
US4450272A (en) * | 1982-05-06 | 1984-05-22 | American Cyanamid Company | Antiatherosclerotic 1-piperazine-thicarboxamides |
IT1167197B (it) * | 1983-07-25 | 1987-05-13 | Bellon Roger Schoum Rbs Pharma | Impiego della fenpiramina quale farmaco antiaggregante piastrinico,vasodilatatore,antitrombotico e antianginoso |
IT1170215B (it) * | 1983-09-12 | 1987-06-03 | Crinos Industria Farmaco | Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta |
IT1206341B (it) * | 1984-02-16 | 1989-04-14 | Crinos Industria Farmaco | Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio. |
-
1983
- 1983-09-12 IT IT22855/83A patent/IT1170214B/it active
-
1984
- 1984-09-07 EP EP84201287A patent/EP0137543B1/fr not_active Expired - Lifetime
- 1984-09-07 CH CH4280/84A patent/CH661870A5/it not_active IP Right Cessation
- 1984-09-07 AT AT84201287T patent/ATE55695T1/de active
- 1984-09-11 DE DE19843433328 patent/DE3433328A1/de active Granted
- 1984-09-12 JP JP59191391A patent/JPH0647545B2/ja not_active Expired - Lifetime
- 1984-09-12 BE BE0/213641A patent/BE900564A/fr not_active IP Right Cessation
-
1988
- 1988-07-05 US US07/218,514 patent/US5081109A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH0647545B2 (ja) | 1994-06-22 |
ATE55695T1 (de) | 1990-09-15 |
CH661870A5 (it) | 1987-08-31 |
DE3433328C2 (fr) | 1993-08-05 |
DE3433328A1 (de) | 1985-03-28 |
IT8322855A0 (it) | 1983-09-12 |
US5081109A (en) | 1992-01-14 |
EP0137543B1 (fr) | 1990-08-22 |
JPS6169722A (ja) | 1986-04-10 |
EP0137543A2 (fr) | 1985-04-17 |
IT1170214B (it) | 1987-06-03 |
EP0137543A3 (en) | 1987-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE900564A (fr) | Composition pharmaceutique pour le traitement d'arteriopathies peripheriques. | |
BE901737A (fr) | Composition pharmaceutique pour le traitement de l'ischemie myocardique aigue. | |
CA2191129A1 (fr) | Medicaments a base de metronidazole ou d'un melange synergetique de metronidazole et de clindamycine | |
CA2330500A1 (fr) | Compositions pharmaceutiques gelifiables | |
FR2347044A1 (fr) | Compositions pharmaceutiques contenant comme ingredients actifs des derives de triazolo-pyrimidines utiles pour le traitement de psoriasis | |
BE901667A (fr) | Composition analgesique et anti-inflammatoire a base de diphenhydramine, leur preparation et leur utilisation. | |
FR2635265B1 (fr) | Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation | |
PT902789E (pt) | Derivados de androsteno | |
DE19875032I2 (de) | Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen | |
DZ2186A1 (fr) | Compositions pharmaceutiques mixtes pour le traitement de l'ostéoporose et procédé pour leur préparation. | |
IE790756L (en) | Cerebral therapeutic agent | |
UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
OA09023A (fr) | Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines. | |
OA06533A (fr) | Dérivés de la pyrimidine, procédés pour leur préparation, compositions pharmaceutiques contenant ces composés et leur utilisation thérapeutique. | |
BE900563A (fr) | Composition pharmaceutique pour le traitement d'etats d'insuffisance renale aigue. | |
RU93004793A (ru) | Производные хиназолина, способ их получения, фармацевтическая композиция на их основе | |
KR950031060A (ko) | 골다공증 치료용 약제학적 조성물 | |
KR890001564A (ko) | 약학적 투여 단위 | |
BE891639A (fr) | Compositions pharmaceutiques contenant de la gamma-butyro-betaine pour le traitement de syndromes provoques par une deficience en l-carnitine | |
KR950016760A (ko) | 치질 치료제 | |
TNSN90021A1 (fr) | Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales | |
BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
BE902796A (fr) | Ester d'acetyl carnitine, sa preparation et son utilisation. | |
FR2434804A1 (fr) | Derives de la n-phenyl-indoline, leur preparation et leur application comme medicaments | |
ITMI922742A0 (it) | Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: CRINOS INDUSTRIA FARMACOBIOLOGICA S.P.A. Effective date: 19970930 |